证券代码：300473 证券简称：德尔股份 阜新德尔汽车部件股份有限公司投资者关系活动记录表 编号：2025-010 公司固态电池下游应用方面，除了新能源汽车市场外，公 司也在开发包括人形机器人、两轮电动车、储能和消费等更广 泛领域的应用场景。 Q6、公司海外生产基地布局情况？ 公司固态电池通过了第三方检测机构的针刺、加热和过充 电等安全试验，以及锂电池国际航运和陆运所需的 UN38.3 认 证，具有较高的安全性。公司固态电池安全性较高的原因，一 方面系公司固态电池制备过程中避免了易燃性材料的使用，从 材料上保障了电池的安全性。其次，公司固态电池目前以氧化 物电解质技术路线为主，而氧化物电解质本身具有较高的化学 稳定性和机械稳定性，有助于提升电池安全性。 Q3、公司固态电池与下游客户的合作进展？ 公司与江西江铃集团新能源汽车有限公司的固态电池合 作项目稳步推进中，目前已经完成电芯样品试生产。除了与江 西江铃集团的战略合作协议外，公司也与其他客户签署了开发 协议或合作意向书。 Q4、公司固态电池目前试生产情况？ 首先，公司固态电池当前已经实现了连续化的试生产。并 且经过调试后，公司试生产过程中的电芯已经具备了较 ...

Group 1: Market Position and Strategy - The company has maintained the number one market share in domestic screw and barrel products for several consecutive years, with a focus on enhancing its competitive edge through technology upgrades, cost control, and deepening customer cooperation [2][3] - Future strategies to expand market share include launching optimized product solutions in niche markets like semi-solid metal injection molding and increasing overseas market penetration in the extruder screw and barrel sector [2][3] Group 2: Customer Relationships and Collaboration - The company collaborates with major international and domestic clients, including Engel and Husky, through customized design and manufacturing, ensuring long-term stable partnerships [3][4] - The cooperation model includes both standard parts supply and joint development of new products, such as ultra-large injection molding machines [3] Group 3: Industry Resilience and Risk Management - The company experienced a significant recovery in performance in 2025 after facing industry adjustments in 2022-2023, attributed to strategies like product structure optimization and overseas market expansion [3] - Maintaining strong relationships with key clients and enhancing product innovation have been crucial for sustaining future operational performance [3] Group 4: Technological Advancements and Production Capacity - The company’s core technologies, such as multi-axis screw polishing and gradient wear-resistant composite processes, exceed industry standards in terms of product precision, hardness, and wear resistance [3] - Current production capacity utilization exceeds 100%, with a planned expansion project expected to increase capacity by approximately 50% by 2028 [3][4] Group 5: Global Market Expansion and Domestic Substitution - The company is actively expanding its presence in overseas markets, particularly in Europe and Southeast Asia, while also focusing on domestic high-end market segments to reduce reliance on imported components [4] - Successful development of the first domestic 8500-ton ultra-large injection molding machine screw and barrel product demonstrates the company's commitment to achieving self-sufficiency in high-end components [4]

Group 1: Market Impact and Strategies - The company’s consumables are not currently included in the centralized procurement scope, and it has not received any formal notifications regarding this matter. If included in the future, the company has competitive advantages such as self-produced raw materials, sufficient capacity, and leading technology, which would make the overall performance impact manageable [1] - The main drivers for improving the company's gross margin include R&D innovation for differentiated premium pricing, optimizing processes and automation to enhance manufacturing quality and efficiency, and actively collaborating with suppliers to achieve quality and efficiency goals [1] Group 2: 3D Printing Business - The 3D printing business has shown significant growth this year and is currently in the ramp-up phase. The company’s 3D printing materials and equipment have gained wide recognition from customers after a year of certification and market testing [2] - The company aims to leverage 3D printing technology and products to enhance sales of planting and repair products, with the technology becoming a core component for achieving efficient, high-precision, and low-cost dental treatments [2] Group 3: Overseas Market Performance - In the first half of 2025, the overseas market generated revenue of 327 million, representing a year-on-year growth of 34%. This growth is attributed to the successful implementation of the company’s major client strategy and the establishment of stable partnerships with key clients after product trials, particularly in the European and African markets [3] - The company employs a differentiated product mix strategy for various niche markets, maintaining product strength and effectively matching solutions to customer needs [3] Group 4: Future Expectations for New Facilities - The company plans to increase production capacity across all product lines based on market trends and strategic planning. The Aidi Te Dental Industrial Park is expected to complete the construction and gradual commissioning of its main production workshops next year [4] - The optimization of the product structure will allow the company to cover a broader customer base, expand market space, and enhance overall profitability, leading to new advancements in production scale and profitability [4]

Group 1: Company Strategy and Competitive Advantage - The company aims to establish a differentiated competitive advantage by aligning with national strategies and regional positioning, focusing on becoming a key capital market platform for Guangxi and serving the Greater Bay Area and the Yangtze Economic Belt [3] - Emphasis on research-driven leadership and collaborative empowerment to enhance core capabilities, focusing on client needs and compliance risk management [3] - Strengthening key business segments such as wealth management, asset management, institutional services, and boutique investment banking to create distinctive competitive advantages [4] Group 2: Research and Development Strategies - The company’s research division aims to become a leading market-oriented think tank, driven by in-depth research and a comprehensive talent structure [5] - Short-term goals include building a complete research team with a tiered talent structure, focusing on market hotspots and developing specialized research teams [5] - Long-term objectives involve enhancing systematic and endogenous capabilities to improve the competitiveness of research operations [5] Group 3: Application of AI in Wealth Management - The company is actively developing an intelligent customer service system, utilizing AI as a core technology engine to restructure knowledge, processes, and services [6] - The implementation of AI is phased and gradual to control risks, aiming to create a "warm" intelligent customer service system that is operationally efficient and service-oriented [6]

Group 1: Company Overview and Operations - The company has established a full supply chain for safety protection products, including core materials and end products [3] - The company is a unique supplier of vacuum storage products for China's aerospace sector, enhancing its market value through technology applications [4] - The company is actively expanding its cross-border channels, focusing on safety protection and outdoor equipment sales on platforms like Amazon and TikTok [4][5] Group 2: Financial Performance and Challenges - The company faced profit declines this year due to internal and external pressures, including increased R&D and B-end customer development investments [3] - Despite short-term profit pressures, the company achieved stable revenue growth in key new business areas and cross-border channels [3] Group 3: Supply Chain and Material Technology - The company has limited impact from upstream raw material supply constraints due to self-research and replacement of previously imported materials [2] - The company has a dedicated pricing management function to ensure supply chain stability and cost control [2] Group 4: Market Expansion and Strategy - The company is expanding its overseas offline channels, focusing on ODM/OEM business while promoting its own brand in international markets [5] - The company is leveraging its core material technology to enhance competitiveness in the overseas industrial sector [5] Group 5: Product Applications and Innovations - The company's self-developed anti-cut materials are being explored for applications in robotics, with ongoing technical exchanges with relevant manufacturers [5] - The company is actively seeking to broaden the application of its material technology in various fields, including aerospace and safety protection [4]

Group 1: Company Growth and Market Position - The company is entering a critical growth phase, transitioning from steady to rapid growth due to significant R&D investments in AI SoC chips, particularly in edge computing and automotive sectors [2][3] - The company aims to become the leading supplier of automotive vision technology within five years, focusing on L2 level and below applications, with a substantial market size and clear competitive landscape [6] - The company has established partnerships with over 30 domestic and international clients, with a strong emphasis on expanding into the Japanese market [6] Group 2: Product Development and Innovations - The company launched several new products at the 2025 Developer Conference, including the SPAD chip for automotive laser radar with detection ranges of 300-600 meters and resolutions from 192 to over 1000 lines [3][4] - New chips for automotive visual perception and driver assistance were introduced, including the SAC8905 and SAC8712, with mass production expected in 2026 [3][4] - The company is also expanding its offerings in edge computing and robotics, with new chips designed for high-end intelligent hardware and various robotic applications [4][9] Group 3: Supply Chain and Competitive Strategy - The company employs an integrated "chip + built-in storage" model, providing a unique commercial advantage and ensuring competitive pricing through large-scale procurement [7] - In response to supply shortages and rising storage costs, the company has seen increased demand for its built-in storage products, enhancing its pricing power [7] - The company has a global sales presence, with over half of its sales coming from international markets, positioning itself as a key supplier in the overseas smart vision market [8][9] Group 4: Future Outlook and Market Trends - The company anticipates sustained growth in its robotics business, with over 10 million units shipped this year and plans to expand into various robotic categories [9] - The company is focused on developing differentiated products that address the needs of the "general robotics" market, targeting all intelligent devices with perception, control, and decision-making capabilities [9]

Group 1: Vaccine Development Progress - The five-component vaccine is currently in Phase III clinical trials, making it the fastest progressing domestic five-component vaccine in China, aiming to break the import monopoly [1] - The recombinant hepatitis B vaccine for chronic hepatitis B patients has received clinical trial approval, targeting a population of approximately 75 million chronic HBV carriers in China [2] - The company is also developing a Klebsiella pneumoniae vaccine to address antibiotic-resistant bacteria, which is a significant global public health challenge [3] Group 2: Market Potential and Growth - The global chronic hepatitis B infection rate is approximately 254 million, with a prevalence rate of 5% to 7% in China, indicating a substantial unmet clinical need [2] - The hepatitis B virus drug market in China is projected to exceed 70 billion yuan by 2030, with an annual compound growth rate of 18% from 2019 to 2030 [2] - The adult vaccination market in China remains underdeveloped compared to developed countries, presenting significant growth opportunities as public awareness increases [3] Group 3: Research and Development Investment - In the first half of 2025, the company invested 334 million yuan in R&D, accounting for 23.96% of its revenue, a 41.52% increase from the same period in 2024 [4] - The company is advancing multiple vaccine candidates, including the four-valent influenza vaccine and the five-component vaccine, with several in various clinical trial phases [5] Group 4: International Expansion - The company is expanding its international presence through partnerships in over 20 countries, focusing on product registration and commercialization [6] - In the first three quarters of 2025, overseas revenue reached 41.9 million yuan, a 324.27% increase year-on-year [7] Group 5: Future Development Strategy - The company plans to enhance its market presence through "internal innovation + external expansion," focusing on core pipeline advantages and optimizing sales networks [8] - Continuous R&D investment will drive the development of multi-component, adult, innovative, and therapeutic vaccines, aiming to build a competitive product matrix [9] Group 6: Shareholder Returns - In June 2025, the company distributed cash dividends amounting to 101 million yuan, representing 49.85% of the net profit attributable to shareholders for 2024 [9] - Since its listing in 2017, the company has distributed a total of 1.885 billion yuan in cash dividends, accounting for 44.66% of the total net profit attributable to shareholders [9]

Group 1: Company Performance and Strategy - The company has strategically focused on the pharmaceutical industry, particularly in the digestive system sector, leading to continuous improvement in product structure and growth quality since 2025 [2]. - The core innovative drug, Tai Xin Zan (替戈拉生片), has seen significant growth, with nearly 2,500 medical institutions adopting it and a sales increase of approximately 140% year-on-year in the first half of 2025 [2][3]. - The gross profit margin for the first three quarters was 51.8%, an increase of 9.0 percentage points, and cash flow turned positive with an increase of 280 million [3]. Group 2: Product Development and Market Position - Tai Xin Zan has achieved full coverage in the medical insurance directory for its three approved indications, which is expected to further stimulate the acid suppression treatment market [5]. - Compared to PPIs, P-CABs like Tai Xin Zan have advantages such as rapid onset, prolonged acid suppression, and less dependency on food intake and genetic factors [4][6]. - The company is advancing its pipeline with the injection of LX22001 entering Phase II clinical trials and the completion of the Phase III clinical research report for Pucanate tablets [6]. Group 3: Financial and Operational Insights - The company plans to raise up to 842.4 million CNY through a specific issuance of A-shares, with the funds allocated for innovative drug research and development, raw material drug expansion, and working capital [9][10]. - The company has implemented a differentiated strategy for its generic drug products, focusing on maintaining supply and quality while controlling costs amid structural adjustments in the industry [8]. - The decrease in expense ratios is attributed to the scale effect from increased sales revenue and enhanced management practices, leading to optimized personnel allocation and budget control [12].

Group 1: Company Overview - Hangzhou Heshun Technology Co., Ltd. was established in 2003, focusing on the R&D, production, and sales of differentiated, functional biaxially oriented polyester films [2] - The company produces various specifications and models of polyester film products, including color optical base films, other functional films, and transparent films, applicable in consumer electronics and automotive sectors [2] - The company aims to expand its product series and application fields while exploring new materials, particularly in high-performance carbon fiber projects for sustainable development [2] Group 2: Market Insights - The carbon fiber market is a key focus area supported by strong national policies, particularly in the commercial aerospace sector, which opens new growth opportunities [4] - The demand for carbon fiber applications is expanding across diverse fields such as commercial aerospace, new energy, and high-end equipment, indicating a broad future growth potential [4][3] Group 3: Product Development and Future Outlook - The company is currently trial-producing three high-value-added new film products, with smooth progress in process verification, expected to gradually release production capacity starting next year [5] - These new products have high profit margins and are anticipated to become a new growth engine for the company's main business, enhancing core competitiveness and profitability [5]

Group 1: Company Overview and Product Applications - The company is actively involved in the aerospace sector, contributing to various space projects such as the Shenzhou, Chang'e, Long March, Tiangong, and Tianwen series, showcasing its technological capabilities and product applications [2][3]. - The company has developed products for commercial aerospace, including the first domestic reusable capture arm and ground static test devices for rockets, indicating its commitment to innovation in this field [3]. Group 2: Strategic Development and Market Positioning - The company focuses on strategic emerging industries, particularly in marine engineering, deep-sea technology, and the Belt and Road Initiative, aiming for high-quality development [4]. - The company has established three main product lines: single permanent mooring steel wire ropes, mooring fiber cables, and deep-sea mooring system accessories, enhancing its market presence in offshore wind power, aquaculture, and photovoltaic applications [4][6]. Group 3: Competitive Advantages in Deep-Sea Economy - Since 2023, the company has obtained multiple DNV factory recognition certificates, marking its transition from providing single mooring products to offering comprehensive mooring solutions [5][6]. - The company is uniquely positioned in the deep-sea mooring market, being the only enterprise capable of complete mooring system design and manufacturing, which is crucial for cost reduction in floating wind turbine projects [6]. Group 4: International Expansion Strategy - The company's "going global" strategy is integral to its growth, with a focus on international market expansion, particularly in the Middle East and Southeast Asia, supported by the Belt and Road Initiative [7]. - The company has established a stable sales network in over 100 countries and regions, having secured projects like the King Fahd Stadium in Saudi Arabia and the national stadium in Serbia, indicating its international outreach [7].